CBER

FDA
Favicon Fierce Pharma

Vinay Prasad is back at the FDA after last month's surprise ouster

“At the FDA’s request,” Vinay Prasad is returning to lead CBER, an HHS spokesperson told Fierce Pharma.
Angus Liu Aug 9, 2025 12:22pm
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Prasad exit signals more permissive FDA for cell and gene field

Jul 31, 2025 9:10am
target reach ladder climb meet win beat competition
Favicon Fierce Pharma

FDA taps new CDER chief as acting CBER head after Prasad exit

Jul 30, 2025 1:10pm
FDA
Favicon Fierce Pharma

FDA investigates 2 deaths after Sarepta Duchenne gene therapy

Jun 25, 2025 10:26am
FDA
Favicon Fierce Pharma

FDA's acting CDER head heads for the exit: report

Jun 23, 2025 1:48pm
parachute sun

BMS banks on Wall Street vet for strategy— Chutes & Ladders

Jun 20, 2025 8:30am